nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Mycophenolic acid—systemic scleroderma	0.471	0.642	CbGbCtD
Entacapone—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.263	0.358	CbGbCtD
Entacapone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000611	CcSEcCtD
Entacapone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000162	0.00061	CcSEcCtD
Entacapone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000162	0.000609	CcSEcCtD
Entacapone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000162	0.000608	CcSEcCtD
Entacapone—Nausea—Mometasone—systemic scleroderma	0.000162	0.000607	CcSEcCtD
Entacapone—Anorexia—Lisinopril—systemic scleroderma	0.000161	0.000606	CcSEcCtD
Entacapone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000161	0.000605	CcSEcCtD
Entacapone—Weight increased—Prednisone—systemic scleroderma	0.000161	0.000604	CcSEcCtD
Entacapone—Ataxia—Methotrexate—systemic scleroderma	0.000161	0.000604	CcSEcCtD
Entacapone—Pain—Mycophenolic acid—systemic scleroderma	0.000161	0.000603	CcSEcCtD
Entacapone—Constipation—Mycophenolic acid—systemic scleroderma	0.000161	0.000603	CcSEcCtD
Entacapone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000603	CcSEcCtD
Entacapone—Weight decreased—Prednisone—systemic scleroderma	0.00016	0.000601	CcSEcCtD
Entacapone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00016	0.0006	CcSEcCtD
Entacapone—Hyperglycaemia—Prednisone—systemic scleroderma	0.000159	0.000599	CcSEcCtD
Entacapone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000595	CcSEcCtD
Entacapone—Hypotension—Lisinopril—systemic scleroderma	0.000158	0.000594	CcSEcCtD
Entacapone—Dizziness—Captopril—systemic scleroderma	0.000158	0.000594	CcSEcCtD
Entacapone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000591	CcSEcCtD
Entacapone—Depression—Prednisone—systemic scleroderma	0.000157	0.00059	CcSEcCtD
Entacapone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000589	CcSEcCtD
Entacapone—Urticaria—Leflunomide—systemic scleroderma	0.000156	0.000588	CcSEcCtD
Entacapone—Abdominal pain—Leflunomide—systemic scleroderma	0.000156	0.000585	CcSEcCtD
Entacapone—Body temperature increased—Leflunomide—systemic scleroderma	0.000156	0.000585	CcSEcCtD
Entacapone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000155	0.000583	CcSEcCtD
Entacapone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000155	0.000582	CcSEcCtD
Entacapone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000581	CcSEcCtD
Entacapone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000581	CcSEcCtD
Entacapone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000154	0.00058	CcSEcCtD
Entacapone—Myocardial infarction—Prednisone—systemic scleroderma	0.000154	0.00058	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000154	0.000579	CcSEcCtD
Entacapone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000579	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000154	0.000578	CcSEcCtD
Entacapone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000154	0.000577	CcSEcCtD
Entacapone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000154	0.000577	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000577	CcSEcCtD
Entacapone—Insomnia—Lisinopril—systemic scleroderma	0.000153	0.000575	CcSEcCtD
Entacapone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000574	CcSEcCtD
Entacapone—Paraesthesia—Lisinopril—systemic scleroderma	0.000152	0.000571	CcSEcCtD
Entacapone—Vomiting—Captopril—systemic scleroderma	0.000152	0.000571	CcSEcCtD
Entacapone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000568	CcSEcCtD
Entacapone—Dyspnoea—Lisinopril—systemic scleroderma	0.000151	0.000567	CcSEcCtD
Entacapone—Rash—Captopril—systemic scleroderma	0.000151	0.000566	CcSEcCtD
Entacapone—Dermatitis—Captopril—systemic scleroderma	0.000151	0.000565	CcSEcCtD
Entacapone—Somnolence—Lisinopril—systemic scleroderma	0.00015	0.000565	CcSEcCtD
Entacapone—Headache—Captopril—systemic scleroderma	0.00015	0.000562	CcSEcCtD
Entacapone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000562	CcSEcCtD
Entacapone—Dyspepsia—Lisinopril—systemic scleroderma	0.000149	0.00056	CcSEcCtD
Entacapone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000149	0.000558	CcSEcCtD
Entacapone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000149	0.000558	CcSEcCtD
Entacapone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000557	CcSEcCtD
Entacapone—Decreased appetite—Lisinopril—systemic scleroderma	0.000147	0.000553	CcSEcCtD
Entacapone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000146	0.000549	CcSEcCtD
Entacapone—Fatigue—Lisinopril—systemic scleroderma	0.000146	0.000548	CcSEcCtD
Entacapone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000548	CcSEcCtD
Entacapone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000546	CcSEcCtD
Entacapone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000545	CcSEcCtD
Entacapone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000145	0.000545	CcSEcCtD
Entacapone—Pain—Lisinopril—systemic scleroderma	0.000145	0.000544	CcSEcCtD
Entacapone—Constipation—Lisinopril—systemic scleroderma	0.000145	0.000544	CcSEcCtD
Entacapone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000541	CcSEcCtD
Entacapone—Bradycardia—Prednisone—systemic scleroderma	0.000144	0.000541	CcSEcCtD
Entacapone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000538	CcSEcCtD
Entacapone—Diarrhoea—Azathioprine—systemic scleroderma	0.000143	0.000536	CcSEcCtD
Entacapone—Haemoglobin—Prednisone—systemic scleroderma	0.000142	0.000534	CcSEcCtD
Entacapone—Nausea—Captopril—systemic scleroderma	0.000142	0.000533	CcSEcCtD
Entacapone—Haemorrhage—Prednisone—systemic scleroderma	0.000141	0.000531	CcSEcCtD
Entacapone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000531	CcSEcCtD
Entacapone—Asthenia—Leflunomide—systemic scleroderma	0.000141	0.000531	CcSEcCtD
Entacapone—Hallucination—Prednisone—systemic scleroderma	0.000141	0.000529	CcSEcCtD
Entacapone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000139	0.000524	CcSEcCtD
Entacapone—Pruritus—Leflunomide—systemic scleroderma	0.000139	0.000523	CcSEcCtD
Entacapone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000139	0.00052	CcSEcCtD
Entacapone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000138	0.00052	CcSEcCtD
Entacapone—Dysuria—Methotrexate—systemic scleroderma	0.000138	0.000519	CcSEcCtD
Entacapone—Dizziness—Azathioprine—systemic scleroderma	0.000138	0.000518	CcSEcCtD
Entacapone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000137	0.000516	CcSEcCtD
Entacapone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000136	0.000511	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000507	CcSEcCtD
Entacapone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000135	0.000506	CcSEcCtD
Entacapone—Diarrhoea—Leflunomide—systemic scleroderma	0.000135	0.000506	CcSEcCtD
Entacapone—Urticaria—Lisinopril—systemic scleroderma	0.000134	0.000505	CcSEcCtD
Entacapone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000504	CcSEcCtD
Entacapone—Body temperature increased—Lisinopril—systemic scleroderma	0.000134	0.000502	CcSEcCtD
Entacapone—Abdominal pain—Lisinopril—systemic scleroderma	0.000134	0.000502	CcSEcCtD
Entacapone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.0005	CcSEcCtD
Entacapone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000133	0.000499	CcSEcCtD
Entacapone—Vomiting—Azathioprine—systemic scleroderma	0.000133	0.000498	CcSEcCtD
Entacapone—Pneumonia—Methotrexate—systemic scleroderma	0.000132	0.000498	CcSEcCtD
Entacapone—Eye disorder—Prednisone—systemic scleroderma	0.000132	0.000497	CcSEcCtD
Entacapone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000497	CcSEcCtD
Entacapone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000495	CcSEcCtD
Entacapone—Rash—Azathioprine—systemic scleroderma	0.000131	0.000494	CcSEcCtD
Entacapone—Dermatitis—Azathioprine—systemic scleroderma	0.000131	0.000493	CcSEcCtD
Entacapone—Depression—Methotrexate—systemic scleroderma	0.000131	0.000493	CcSEcCtD
Entacapone—Flushing—Prednisone—systemic scleroderma	0.000131	0.000493	CcSEcCtD
Entacapone—Headache—Azathioprine—systemic scleroderma	0.000131	0.000491	CcSEcCtD
Entacapone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00049	CcSEcCtD
Entacapone—Dizziness—Leflunomide—systemic scleroderma	0.00013	0.000489	CcSEcCtD
Entacapone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000484	CcSEcCtD
Entacapone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000129	0.000483	CcSEcCtD
Entacapone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000128	0.000481	CcSEcCtD
Entacapone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000481	CcSEcCtD
Entacapone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000476	CcSEcCtD
Entacapone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000476	CcSEcCtD
Entacapone—Sweating—Methotrexate—systemic scleroderma	0.000126	0.000474	CcSEcCtD
Entacapone—Haematuria—Methotrexate—systemic scleroderma	0.000126	0.000472	CcSEcCtD
Entacapone—Vomiting—Leflunomide—systemic scleroderma	0.000125	0.00047	CcSEcCtD
Entacapone—Alopecia—Prednisone—systemic scleroderma	0.000125	0.00047	CcSEcCtD
Entacapone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000125	0.000468	CcSEcCtD
Entacapone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000125	0.000468	CcSEcCtD
Entacapone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000124	0.000467	CcSEcCtD
Entacapone—Epistaxis—Methotrexate—systemic scleroderma	0.000124	0.000467	CcSEcCtD
Entacapone—Rash—Leflunomide—systemic scleroderma	0.000124	0.000466	CcSEcCtD
Entacapone—Dermatitis—Leflunomide—systemic scleroderma	0.000124	0.000466	CcSEcCtD
Entacapone—Mental disorder—Prednisone—systemic scleroderma	0.000124	0.000466	CcSEcCtD
Entacapone—Nausea—Azathioprine—systemic scleroderma	0.000124	0.000465	CcSEcCtD
Entacapone—Headache—Leflunomide—systemic scleroderma	0.000123	0.000463	CcSEcCtD
Entacapone—Malnutrition—Prednisone—systemic scleroderma	0.000123	0.000463	CcSEcCtD
Entacapone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000123	0.000462	CcSEcCtD
Entacapone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000459	CcSEcCtD
Entacapone—Asthenia—Lisinopril—systemic scleroderma	0.000121	0.000456	CcSEcCtD
Entacapone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000455	CcSEcCtD
Entacapone—Pruritus—Lisinopril—systemic scleroderma	0.00012	0.00045	CcSEcCtD
Entacapone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000119	0.000449	CcSEcCtD
Entacapone—Haemoglobin—Methotrexate—systemic scleroderma	0.000119	0.000446	CcSEcCtD
Entacapone—Rash—Mycophenolic acid—systemic scleroderma	0.000118	0.000445	CcSEcCtD
Entacapone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000118	0.000445	CcSEcCtD
Entacapone—Haemorrhage—Methotrexate—systemic scleroderma	0.000118	0.000444	CcSEcCtD
Entacapone—Hepatitis—Methotrexate—systemic scleroderma	0.000118	0.000444	CcSEcCtD
Entacapone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000442	CcSEcCtD
Entacapone—Headache—Mycophenolic acid—systemic scleroderma	0.000118	0.000442	CcSEcCtD
Entacapone—Pharyngitis—Methotrexate—systemic scleroderma	0.000117	0.000441	CcSEcCtD
Entacapone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000117	0.00044	CcSEcCtD
Entacapone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000117	0.00044	CcSEcCtD
Entacapone—Nausea—Leflunomide—systemic scleroderma	0.000117	0.000439	CcSEcCtD
Entacapone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000117	0.000439	CcSEcCtD
Entacapone—Vision blurred—Prednisone—systemic scleroderma	0.000116	0.000436	CcSEcCtD
Entacapone—Urethral disorder—Methotrexate—systemic scleroderma	0.000116	0.000435	CcSEcCtD
Entacapone—Diarrhoea—Lisinopril—systemic scleroderma	0.000116	0.000435	CcSEcCtD
Entacapone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000114	0.000429	CcSEcCtD
Entacapone—Visual impairment—Methotrexate—systemic scleroderma	0.000114	0.000428	CcSEcCtD
Entacapone—Agitation—Prednisone—systemic scleroderma	0.000113	0.000425	CcSEcCtD
Entacapone—Angioedema—Prednisone—systemic scleroderma	0.000113	0.000423	CcSEcCtD
Entacapone—Dizziness—Lisinopril—systemic scleroderma	0.000112	0.00042	CcSEcCtD
Entacapone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000112	0.00042	CcSEcCtD
Entacapone—Nausea—Mycophenolic acid—systemic scleroderma	0.000112	0.000419	CcSEcCtD
Entacapone—Malaise—Prednisone—systemic scleroderma	0.000111	0.000417	CcSEcCtD
Entacapone—Vertigo—Prednisone—systemic scleroderma	0.000111	0.000416	CcSEcCtD
Entacapone—Eye disorder—Methotrexate—systemic scleroderma	0.00011	0.000415	CcSEcCtD
Entacapone—Syncope—Prednisone—systemic scleroderma	0.00011	0.000415	CcSEcCtD
Entacapone—Cardiac disorder—Methotrexate—systemic scleroderma	0.00011	0.000412	CcSEcCtD
Entacapone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000109	0.00041	CcSEcCtD
Entacapone—Loss of consciousness—Prednisone—systemic scleroderma	0.000108	0.000407	CcSEcCtD
Entacapone—Vomiting—Lisinopril—systemic scleroderma	0.000108	0.000404	CcSEcCtD
Entacapone—Rash—Lisinopril—systemic scleroderma	0.000107	0.000401	CcSEcCtD
Entacapone—Convulsion—Prednisone—systemic scleroderma	0.000107	0.000401	CcSEcCtD
Entacapone—Dermatitis—Lisinopril—systemic scleroderma	0.000107	0.0004	CcSEcCtD
Entacapone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000106	0.0004	CcSEcCtD
Entacapone—Hypertension—Prednisone—systemic scleroderma	0.000106	0.000399	CcSEcCtD
Entacapone—Headache—Lisinopril—systemic scleroderma	0.000106	0.000398	CcSEcCtD
Entacapone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000394	CcSEcCtD
Entacapone—Myalgia—Prednisone—systemic scleroderma	0.000105	0.000394	CcSEcCtD
Entacapone—Anxiety—Prednisone—systemic scleroderma	0.000104	0.000392	CcSEcCtD
Entacapone—Alopecia—Methotrexate—systemic scleroderma	0.000104	0.000392	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000104	0.000391	CcSEcCtD
Entacapone—Discomfort—Prednisone—systemic scleroderma	0.000104	0.000389	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—systemic scleroderma	0.000104	0.000389	CcSEcCtD
Entacapone—Malnutrition—Methotrexate—systemic scleroderma	0.000103	0.000387	CcSEcCtD
Entacapone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000381	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—systemic scleroderma	0.000101	0.000379	CcSEcCtD
Entacapone—Nausea—Lisinopril—systemic scleroderma	0.000101	0.000378	CcSEcCtD
Entacapone—Oedema—Prednisone—systemic scleroderma	0.0001	0.000378	CcSEcCtD
Entacapone—Back pain—Methotrexate—systemic scleroderma	9.95e-05	0.000374	CcSEcCtD
Entacapone—Shock—Prednisone—systemic scleroderma	9.89e-05	0.000371	CcSEcCtD
Entacapone—Nervous system disorder—Prednisone—systemic scleroderma	9.86e-05	0.00037	CcSEcCtD
Entacapone—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.8e-05	0.000368	CcSEcCtD
Entacapone—Skin disorder—Prednisone—systemic scleroderma	9.76e-05	0.000367	CcSEcCtD
Entacapone—Hyperhidrosis—Prednisone—systemic scleroderma	9.72e-05	0.000365	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—systemic scleroderma	9.7e-05	0.000364	CcSEcCtD
Entacapone—Anorexia—Prednisone—systemic scleroderma	9.58e-05	0.00036	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—systemic scleroderma	9.55e-05	0.000359	CcSEcCtD
Entacapone—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000354	CcSEcCtD
Entacapone—Rash—Mycophenolate mofetil—systemic scleroderma	9.35e-05	0.000351	CcSEcCtD
Entacapone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.34e-05	0.000351	CcSEcCtD
Entacapone—Headache—Mycophenolate mofetil—systemic scleroderma	9.29e-05	0.000349	CcSEcCtD
Entacapone—Malaise—Methotrexate—systemic scleroderma	9.28e-05	0.000349	CcSEcCtD
Entacapone—Vertigo—Methotrexate—systemic scleroderma	9.25e-05	0.000347	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—systemic scleroderma	9.21e-05	0.000346	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.16e-05	0.000344	CcSEcCtD
Entacapone—Insomnia—Prednisone—systemic scleroderma	9.09e-05	0.000341	CcSEcCtD
Entacapone—Paraesthesia—Prednisone—systemic scleroderma	9.02e-05	0.000339	CcSEcCtD
Entacapone—Cough—Methotrexate—systemic scleroderma	8.98e-05	0.000337	CcSEcCtD
Entacapone—Convulsion—Methotrexate—systemic scleroderma	8.92e-05	0.000335	CcSEcCtD
Entacapone—Dyspepsia—Prednisone—systemic scleroderma	8.85e-05	0.000332	CcSEcCtD
Entacapone—Nausea—Mycophenolate mofetil—systemic scleroderma	8.81e-05	0.000331	CcSEcCtD
Entacapone—Chest pain—Methotrexate—systemic scleroderma	8.76e-05	0.000329	CcSEcCtD
Entacapone—Myalgia—Methotrexate—systemic scleroderma	8.76e-05	0.000329	CcSEcCtD
Entacapone—Decreased appetite—Prednisone—systemic scleroderma	8.74e-05	0.000328	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.7e-05	0.000327	CcSEcCtD
Entacapone—Fatigue—Prednisone—systemic scleroderma	8.66e-05	0.000325	CcSEcCtD
Entacapone—Discomfort—Methotrexate—systemic scleroderma	8.66e-05	0.000325	CcSEcCtD
Entacapone—Constipation—Prednisone—systemic scleroderma	8.59e-05	0.000323	CcSEcCtD
Entacapone—Confusional state—Methotrexate—systemic scleroderma	8.47e-05	0.000318	CcSEcCtD
Entacapone—Feeling abnormal—Prednisone—systemic scleroderma	8.28e-05	0.000311	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—systemic scleroderma	8.24e-05	0.000309	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—systemic scleroderma	8.22e-05	0.000309	CcSEcCtD
Entacapone—Gastrointestinal pain—Prednisone—systemic scleroderma	8.22e-05	0.000309	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—systemic scleroderma	8.16e-05	0.000306	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—systemic scleroderma	8.12e-05	0.000305	CcSEcCtD
Entacapone—Anorexia—Methotrexate—systemic scleroderma	8.01e-05	0.000301	CcSEcCtD
Entacapone—Urticaria—Prednisone—systemic scleroderma	7.98e-05	0.0003	CcSEcCtD
Entacapone—Body temperature increased—Prednisone—systemic scleroderma	7.94e-05	0.000298	CcSEcCtD
Entacapone—Abdominal pain—Prednisone—systemic scleroderma	7.94e-05	0.000298	CcSEcCtD
Entacapone—Hypotension—Methotrexate—systemic scleroderma	7.85e-05	0.000295	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.65e-05	0.000287	CcSEcCtD
Entacapone—Insomnia—Methotrexate—systemic scleroderma	7.6e-05	0.000285	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—systemic scleroderma	7.54e-05	0.000283	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—systemic scleroderma	7.49e-05	0.000281	CcSEcCtD
Entacapone—Somnolence—Methotrexate—systemic scleroderma	7.47e-05	0.00028	CcSEcCtD
Entacapone—Hypersensitivity—Prednisone—systemic scleroderma	7.4e-05	0.000278	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—systemic scleroderma	7.39e-05	0.000278	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—systemic scleroderma	7.3e-05	0.000274	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.25e-05	0.000272	CcSEcCtD
Entacapone—Fatigue—Methotrexate—systemic scleroderma	7.24e-05	0.000272	CcSEcCtD
Entacapone—Asthenia—Prednisone—systemic scleroderma	7.21e-05	0.000271	CcSEcCtD
Entacapone—Pain—Methotrexate—systemic scleroderma	7.18e-05	0.00027	CcSEcCtD
Entacapone—Pruritus—Prednisone—systemic scleroderma	7.11e-05	0.000267	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—systemic scleroderma	6.92e-05	0.00026	CcSEcCtD
Entacapone—Diarrhoea—Prednisone—systemic scleroderma	6.88e-05	0.000258	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.87e-05	0.000258	CcSEcCtD
Entacapone—Urticaria—Methotrexate—systemic scleroderma	6.67e-05	0.000251	CcSEcCtD
Entacapone—Dizziness—Prednisone—systemic scleroderma	6.65e-05	0.00025	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—systemic scleroderma	6.64e-05	0.000249	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—systemic scleroderma	6.64e-05	0.000249	CcSEcCtD
Entacapone—Vomiting—Prednisone—systemic scleroderma	6.39e-05	0.00024	CcSEcCtD
Entacapone—Rash—Prednisone—systemic scleroderma	6.34e-05	0.000238	CcSEcCtD
Entacapone—Dermatitis—Prednisone—systemic scleroderma	6.33e-05	0.000238	CcSEcCtD
Entacapone—Headache—Prednisone—systemic scleroderma	6.3e-05	0.000236	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—systemic scleroderma	6.19e-05	0.000232	CcSEcCtD
Entacapone—Asthenia—Methotrexate—systemic scleroderma	6.03e-05	0.000226	CcSEcCtD
Entacapone—Nausea—Prednisone—systemic scleroderma	5.97e-05	0.000224	CcSEcCtD
Entacapone—Pruritus—Methotrexate—systemic scleroderma	5.94e-05	0.000223	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—systemic scleroderma	5.75e-05	0.000216	CcSEcCtD
Entacapone—Dizziness—Methotrexate—systemic scleroderma	5.55e-05	0.000209	CcSEcCtD
Entacapone—Vomiting—Methotrexate—systemic scleroderma	5.34e-05	0.000201	CcSEcCtD
Entacapone—Rash—Methotrexate—systemic scleroderma	5.3e-05	0.000199	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—systemic scleroderma	5.29e-05	0.000199	CcSEcCtD
Entacapone—Headache—Methotrexate—systemic scleroderma	5.26e-05	0.000198	CcSEcCtD
Entacapone—Nausea—Methotrexate—systemic scleroderma	4.99e-05	0.000187	CcSEcCtD
